Benefits and costs of vaccination.
Vaccination programmes supported by the WHO and other organizations have dramatically reduced disease in developing countries, but there remains a need to extend coverage rates and expand the number of vaccines included. In industrialized countries, where paediatric vaccination is almost universal, there will be an increasing opportunity to protect against diseases which occur in later years.
Dejonghe
P
P
SmithKline Beecham Biologicals, Rixensart, Belgium.
Parkinson
B
B
D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D014943:Global Health; D006509:Hepatitis B / Q000191:economics / Q000517:prevention & control; D006801:Humans; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D009784:Occupational Diseases / Q000191:economics / Q000517:prevention & control; D010567:Pertussis Vaccine / Q000009:adverse effects; D011051:Poliomyelitis / Q000517:prevention & control; D012411:Rubella Vaccine; D012449:Safety; D014611:Vaccination / Q000009:adverse effects / Q000191:economics* / Q000706:statistics & numerical data; D026712:Value of Life; D014917:Whooping Cough / Q000517:prevention & control; D014944:World Health Organization
D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D010567:Pertussis Vaccine; D012411:Rubella Vaccine